<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101686084</journal-id>
<journal-id journal-id-type="pubmed-jr-id">45425</journal-id>
<journal-id journal-id-type="nlm-ta">Expert Rev Precis Med Drug Dev</journal-id>
<journal-id journal-id-type="iso-abbrev">Expert Rev Precis Med Drug Dev</journal-id>
<journal-title-group>
<journal-title>Expert review of precision medicine and drug development</journal-title>
</journal-title-group>
<issn pub-type="epub">2380-8993</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31286058</article-id>
<article-id pub-id-type="pmc">6613936</article-id>
<article-id pub-id-type="doi">10.1080/23808993.2019.1617632</article-id>
<article-id pub-id-type="manuscript">NIHMS1033076</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Use of big data in drug development for precision medicine: an
update</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Qian</surname>
<given-names>Tongqi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Shijia</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoshida</surname>
<given-names>Yujin</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Genetics and Genomic Sciences and Icahn
Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount
Sinai, New York, NY, USA.</aff>
<aff id="A2"><label>2</label>Liver Tumor Translational Research Program, Simmons
Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of
Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
75390, USA</aff>
<author-notes>
<corresp id="CR1"><label>*</label><bold>Corresponding authors:</bold> Shijia Zhu,
Liver Tumor Translational Research Program, Simmons Comprehensive, Cancer
Center, Division of Digestive and Liver Diseases, Department of Internal
Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines
Blvd, Y5.222, Dallas, Texas 75390, <email>Shijia.Zhu@UTSouthwestern.edu</email>,
Yujin Hoshida, Liver Tumor Translational Research Program, Simmons
Comprehensive, Cancer Center, Division of Digestive and Liver Diseases,
Department of Internal Medicine, University of Texas Southwestern Medical
Center, 5323 Harry Hines Blvd, Y5.222, Dallas, Texas 75390,
<email>Yujin.Hoshida@UTSouthwestern.edu</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P27">Declaration of interest</p>
<p id="P28">The authors have no relevant affiliations or financial involvement with
any organization or entity with a financial interest in or financial conflict
with the subject matter or materials discussed in the manuscript. This includes
employment, consultancies, honoraria, stock ownership or options, expert
testimony, grants or patents received or pending, or royalties</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>08</day>
<month>7</month>
<year>2019</year>
</pub-date>
<volume>4</volume>
<issue>3</issue>
<fpage>189</fpage>
<lpage>200</lpage>
<!--elocation-id from pubmed: 10.1080/23808993.2019.1617632-->
<self-uri xlink:href="https://www.tandfonline.com/doi/full/10.1080/23808993.2019.1617632"></self-uri>
<abstract id="ABS1">
<sec id="S1">
<title>Introduction:</title>
<p id="P1">Big-data-driven drug development resources and methodologies have
been evolving with ever-expanding data from large-scale biological
experiments, clinical trials, and medical records from participants in data
collection initiatives. The enrichment of biological- and
clinical-context-specific large-scale data has enabled computational
inference more relevant to real-world biomedical research, particularly
identification of therapeutic targets and drugs for specific diseases and
clinical scenarios.</p>
</sec>
<sec id="S2">
<title>Areas covered:</title>
<p id="P2">Here we overview recent progresses made in the fields: new
big-data-driven approach to therapeutic target discovery, candidate drug
prioritization, inference of clinical toxicity, and machine-learning methods
in drug discovery.</p>
</sec>
<sec id="S3">
<title>Expert opinion:</title>
<p id="P3">In the near future, much larger volumes and complex datasets for
precision medicine will be generated, e.g., individual and longitudinal
multi-omic, and direct-to-consumer datasets. Closer collaborations between
experts with different backgrounds would also be required to better
translate analytic results into prognosis and treatment in the clinical
practice. Meanwhile, cloud computing with protected patient privacy would
become more routine analytic practice to fill the gaps within data
integration along with the advent of big-data. To conclude, integration of
multitudes of data generated for each individual along with techniques
tailored for big-data analytics may eventually enable us to achieve
precision medicine.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Big data</kwd>
<kwd>drug development</kwd>
<kwd>precision medicine</kwd>
<kwd>high-throughput screen</kwd>
<kwd>machine learning</kwd>
<kwd>in silico drug discovery</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>